This leaflet explains the use, benefits, risks, and side effects of Moderna's bivalent COVID-19 vaccine for ages 6 months and up.
This document provides information about the Moderna bivalent COVID-19 vaccine, including its purpose, administration, age groups, contraindications, side effects, and reporting procedures. It is intended for recipients and caregivers to understand the vaccine’s risks and benefits during the ongoing COVID-19 pandemic. The vaccine is authorized for emergency use (EUA) by the FDA but not approved for general use. It targets both original and Omicron BA.4/BA.5 SARS-CoV-2 spike proteins. This manual is written in Chinese.
Those who had a severe allergic reaction to any component of this or other Moderna COVID-19 vaccines.
It is used to prevent COVID-19 caused by SARS-CoV-2 virus.
It is for individuals aged 6 months and older.
The bivalent vaccine encodes both original SARS-CoV-2 and Omicron BA.4/BA.5 spike proteins, while the monovalent vaccine encodes only the original SARS-CoV-2 spike protein.